Showing results (2381-2390 of 5,884) with videos related to

Sort By:
Pageof 589
Infection|March 10, 2004
Evaluation of CSF glial fibrillary acidic protein (GFAP) as a putative marker for HIV-associated dementiaB Sporer, U Missler, O Magerkurth, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1994
[Technique and results of the "Mini-Bricker" urinary tract diversion after total cystectomy for bladder tumors]C Pfister, D Prapotnich, A Mombet, et al.
Arzneimittel-Forschung|January 1, 1983
Double-blind co-operative trial to compare trimethoprim-sulfalene and co-trimoxazole in the treatment of lower respiratory tract infectionsR Ferlinz, J Lorenz, K Micka, et al.
Osteoarthritis and Cartilage|December 6, 2005
Osteogenic protein-1 promotes the formation of tissue-engineered cartilage using the alginate-recovered-chondrocyte methodK Masuda, B E Pfister, R L Sah, et al.
EJVES Short Reports|September 1, 2017
Inferior Mesenteric Artery Side Branch for Selected Patients with Endovascular Aortic Aneurysm RepairK Pfister, P M Kasprzak, H Apfelbeck, et al.
Journal of Perinatal Medicine|January 1, 1991
"Neonatal adaptation of energy and protein metabolism"J L Micheli, K Schisler, Y Schutz, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 22, 2009
A new Bayesian method to forecast and fine tune individual hemodialysis doseM Pfister, D E Uehlinger, A M Hung, et al.
Chemosphere|February 11, 2009
Determination of PAH, PCB, and OCP in water from the Three Gorges Reservoir accumulated by semipermeable membrane devices (SPMD)Jingxian Wang, Yonghong Bi, Gerd Pfister, et al.
American Journal of Hematology|April 26, 2005
High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosisMichaela Graf, Susanne Reif, Karin Hecht, et al.
Clinical Pharmacology and Therapeutics|August 6, 2010
Quantification of apixaban's therapeutic utility in prevention of venous thromboembolism: selection of phase III trial doseT A Leil, Y Feng, L Zhang, et al.
Pageof 589